CNF2024

DRUG2 trials

Sponsors

Biogen

Conditions

Breast CancerLymphomaTumors

Phase 1

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

CompletedNCT00345189

BiogenLymphoma, Tumors

Start: 2006-02-28End: 2009-04-30Updated: 2009-07-14

CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study

CompletedNCT00412412

BiogenBreast Cancer

Start: 2007-12-31End: 2011-04-30Updated: 2012-06-08